People diagnosed with attention-deficit/hyperactivity disorder (ADHD) face a roughly 71% higher overall risk of early death ...
Among people with ADHD, those taking prescribed ADHD medication had a 25% lower risk of death from any cause compared to ...
Adults with ADHD face a substantially higher risk for mild cognitive impairment or dementia, with genetic findings ...
Only rheumatoid arthritis was excluded.
A large review finds that ADHD is linked to a higher risk of dying from any cause, but also that treatment can lower this ...
A cross-sectional study of 1,594 Japanese children found that ADHD was associated with worse mental health, school ...
Children with ADHD process unexpected sounds differently than their peers, but these brain responses change as they grow. New research shows heightened sensitivity to sudden noises in early childhood ...
Initiating pharmacotherapy for attention-deficit/hyperactivity disorder was associated with a reduction in self-harm events, emphasizing the clinical importance of timely intervention.
A 2026 narrative review finds that continuous performance tests reveal group-level attentional differences in children with ...
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that ...
ADHD in women is often missed. Symptoms look more like overwhelm than hyperactivity, shifting across life stages and often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results